Genmab AS - Company Profile
Powered by 
All the sales intelligence you need on Genmab AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Genmab AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Genmab AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Genmab AS (Genmab) focuses on the research and development of antibody therapies for the treatment of cancer. Focus on research and development activities, proprietary technology platforms, and collaborations are its major strengths, even as clinical trial suspension is a cause for concern to the company. Strategic agreement, regulatory approvals and the market potential: hodgkin lymphoma provide growth opportunities to the company. However, tightening of the FDA’s regulatory oversight, uncertain R&D outcomes, and competitive pressure could affect the company’s business operations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer